Christopher Slapak - Net Worth and Insider Trading

Christopher Slapak Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Slapak owns 1 companies in total, including Vor Biopharma Inc (VOR) .

Click here to see the complete history of Christopher Slapak’s form 4 insider trades.

Insider Ownership Summary of Christopher Slapak

Ticker Comapny Transaction Date Type of Owner
VOR Vor Biopharma Inc 2021-02-04 Chief Medical Officer

Christopher Slapak Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Slapak Ownership Network

Ownership Network List of Christopher Slapak

No Data

Ownership Network Relation of Christopher Slapak

Insider Network Chart

Christopher Slapak Owned Company Details

What does Vor Biopharma Inc do?

Who are the key executives at Vor Biopharma Inc?

Christopher Slapak is the Chief Medical Officer of Vor Biopharma Inc. Other key executives at Vor Biopharma Inc include Chief Medical Officer Eyal C. Attar , 10 percent owner 5am Ventures Vi, L.p. , and director & 10 percent owner Kush Parmar .

Vor Biopharma Inc (VOR) Insider Trades Summary

Over the past 18 months, Christopher Slapak made no insider transaction in Vor Biopharma Inc (VOR). Other recent insider transactions involving Vor Biopharma Inc (VOR) include a net sale of 29,760 shares made by Eyal C. Attar ,

In summary, during the past 3 months, insiders sold 4,781 shares of Vor Biopharma Inc (VOR) in total and bought 0 shares, with a net sale of 4,781 shares. During the past 18 months, 29,760 shares of Vor Biopharma Inc (VOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 29,760 shares.

Vor Biopharma Inc (VOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vor Biopharma Inc Insider Transactions

No Available Data

Christopher Slapak Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Slapak. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Christopher Slapak's mailing address is: Cambridge Ma 02140.